Neuronetics to Report Second Quarter 2022 Financial and Operating Results and Host Conference Call
July 19, 2022 08:30 ET
|
Neuronetics
MALVERN, Pa., July 19, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of Anxious Depression
July 19, 2022 07:00 ET
|
Neuronetics
MALVERN, Pa., July 19, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Recognized as Top Non-Invasive Devices Provider in 2022
July 13, 2022 08:31 ET
|
Neuronetics
MALVERN, Pa., July 13, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Announces Positive TMS Coverage Policies to Expand Patient Access to NeuroStar TMS Therapy for Mental Health
July 11, 2022 16:46 ET
|
Neuronetics
MALVERN, Pa., July 11, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever...
Neuronetics to Present at the William Blair 42nd Annual Growth Stock Conference
May 25, 2022 16:30 ET
|
Neuronetics
MALVERN, Pa., May 25, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing, and marketing products that improve...
New Peer-Reviewed Data Continue to Further Best Practices with NeuroStar® Advanced Therapy
May 17, 2022 08:31 ET
|
Neuronetics
Published in Brain Stimulation Journal, study describes insights from world’s largest depression registry MALVERN, Pa., May 17, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a...
Neuronetics Reports First Quarter 2022 Financial and Operating Results
May 12, 2022 07:30 ET
|
Neuronetics
MALVERN, Pa., May 12, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever...
Neuronetics and Transformations Care Network Announce Extended Commercial Partnership
May 11, 2022 16:30 ET
|
Neuronetics
MALVERN, Pa., May 11, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever...
Neuronetics TMS Leadership on Display at Clinical TMS Society Annual Meeting
May 11, 2022 08:31 ET
|
Neuronetics
MALVERN, Pa., May 11, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Files Federal Lawsuit Against Brainsway for Misleading Psychiatrists and Patients
May 11, 2022 08:00 ET
|
Neuronetics
MALVERN, Pa., May 11, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...